Skip to main content

Table 1 The comparison of the 2D, 3D globe, and organ-specific GP (%) for 30 NPC cases with different gamma criteria

From: Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis

 

3%/3 mm

2%/2 mm

1%/1 mm

GP (%)

GP (%)

GP (%)

Global GP (%)

 2D phantom verification

96.4 ± 2.9 [90.1–99.7]

90.2 ± 5.5 [74.9–99.0]

60.9 ± 9.6 [41.2–84.6]

 3Dreconstruction verification

97.7 ± 3.2 [86.3–99.6]

91.3 ± 6.2 [71.1–98.7]

67.8 ± 9.9 [40.6–88.7]

p

0.002

0.152

0.000

Organ GP (%) of 3D reconstruction verification

 PTVnx (70 Gy)

93.78 ± 11.03 [57–100]

79.24 ± 22.1 [23.1–99.8]

46.55 ± 24.83 [4–85.8]

 PTV1 (60 Gy)

95.61 ± 7.31 [72.6–100]

83.12 ± 17.19 [41.2–99.9]

50.47 ± 21.37 [8–87.9]

 PTV2 (54 Gy)

94.41 ± 7.48 [67.4–99.8]

81.32 ± 11.81 [55.3–99.4]

50.45 ± 15.46 [22.4–87.4]

 Spinal cord

98.24 ± 2.32 [90.2–100]

89.09 ± 8.45[64.3–100]

57.43 ± 14.18[30.9–85.3]

 Brainstem

99.17 ± 1.48 [93.7–100]

94.00 ± 7.41[71.9–100]

65.41 ± 19.49 [14.3–91]

 Left parotid gland

99.22 ± 2.78 [84.8–100]

95.85 ± 6.01[72.3–100]

78.84 ± 12.96 [49.1–96.8]

 Right parotid gland

99.25 ± 2.21 [89.9–100]

95.44 ± 6.15[75.8–100]

76.50 ± 15.47 [43.1–97.2]

 Left temporal lobe

99.40 ± 1.78 [92.4–100]

95.14 ± 7.51[65.6–100]

70.03 ± 24.06 [18.2–95.1]

 Right temporal lobe

99.35 ± 1.61 [92.6–100]

95 ± 6.60 [71.6–100]

69.1 ± 21.43 [11.6–96.1]

 Larynx

96.52 ± 5.21 [78.4–100]

86.38 ± 13.85[50.6–100]

55.88 ± 26.23 [12.8–90.9]

  1. p indicates significance on the two-tailed Student t-test
  2. Abbreviations:GP (%)-gamma pass rate (%); PTV - planning target volume; NPC - nasopharyngeal carcinoma;